Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1966 1
1967 1
1970 1
1973 1
1974 2
1975 2
1977 1
1979 3
1980 1
1981 4
1982 9
1983 12
1984 13
1985 11
1986 3
1987 4
1988 7
1989 7
1990 4
1991 19
1992 5
1993 11
1994 18
1995 26
1996 26
1997 24
1998 21
1999 24
2000 28
2001 37
2002 46
2003 48
2004 56
2005 87
2006 82
2007 109
2008 123
2009 115
2010 114
2011 149
2012 155
2013 194
2014 235
2015 269
2016 272
2017 261
2018 314
2019 365
2020 455
2021 490
2022 576
2023 63
Text availability
Article attribute
Article type
Publication date

Search Results

4,407 results
Results by year
Filters applied: . Clear all
Page 1
Ultrasound-controllable engineered bacteria for cancer immunotherapy.
Abedi MH, Yao MS, Mittelstein DR, Bar-Zion A, Swift MB, Lee-Gosselin A, Barturen-Larrea P, Buss MT, Shapiro MG. Abedi MH, et al. Among authors: yao ms. Nat Commun. 2022 Mar 24;13(1):1585. doi: 10.1038/s41467-022-29065-2. Nat Commun. 2022. PMID: 35332124 Free PMC article.
Long non-coding RNA MALAT1 regulates retinal neurodegeneration through CREB signaling.
Yao J, Wang XQ, Li YJ, Shan K, Yang H, Wang YN, Yao MD, Liu C, Li XM, Shen Y, Liu JY, Cheng H, Yuan J, Zhang YY, Jiang Q, Yan B. Yao J, et al. Among authors: yao md. EMBO Mol Med. 2022 Dec 7;14(12):e16660. doi: 10.15252/emmm.202216660. EMBO Mol Med. 2022. PMID: 36478157 Free PMC article. No abstract available.
Dorzagliatin add-on therapy to metformin in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled phase 3 trial.
Yang W, Zhu D, Gan S, Dong X, Su J, Li W, Jiang H, Zhao W, Yao M, Song W, Lu Y, Zhang X, Li H, Wang G, Qiu W, Yuan G, Ma J, Li W, Li Z, Wang X, Zeng J, Yang Z, Liu J, Liang Y, Lu S, Zhang H, Liu H, Liu P, Fan K, Jiang X, Li Y, Su Q, Ning T, Tan H, An Z, Jiang Z, Liu L, Zhou Z, Zhang Q, Li X, Shan Z, Xue Y, Mao H, Shi L, Ye S, Zhang X, Sun J, Li P, Yang T, Li F, Lin J, Zhang Z, Zhao Y, Li R, Guo X, Yao Q, Lu W, Qu S, Li H, Tan L, Wang W, Yao Y, Chen D, Li Y, Gao J, Hu W, Fei X, Wu T, Dong S, Jin W, Li C, Zhao D, Feng B, Zhao Y, Zhang Y, Li X, Chen L. Yang W, et al. Among authors: yao m. Nat Med. 2022 May;28(5):974-981. doi: 10.1038/s41591-022-01803-5. Epub 2022 May 12. Nat Med. 2022. PMID: 35551292 Free PMC article. Clinical Trial.
4,407 results